MedTrace Logo

Vaginal Detection of Orally Delivered Probiotic Strains in Healthy Women

NCT07246161 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-11-26

No results posted yet for this study

Summary

The purpose of the present study is to obtain more information on the transit of orally ingested probiotics to the vagina.

Conditions

  • Focus is on Healthy Subjects

Interventions

OTHER

Probiotic Formula 1

Includes 2 different probiotic strains differing from other intervention groups.

OTHER

Probiotic Formula 2

Includes 2 different probiotic strains differing from other intervention groups.

OTHER

Probiotic Formula 3

Includes 2 different probiotic strains differing from other intervention groups.

Sponsors & Collaborators

  • Lallemand Health Solutions

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-20
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07246161 on ClinicalTrials.gov